Integral Derivatives’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$307K Sell
1,900
-4,200
-69% -$669K 0.01% 502
2017
Q4
$891K Buy
+6,100
New +$869K 0.02% 522
2017
Q3
Sell
-9,800
Closed -$1.23M 1150
2017
Q2
$1.23M Buy
9,800
+7,100
+263% +$849K 0.03% 424
2017
Q1
$321K Sell
2,700
-3,600
-57% -$433K 0.01% 883
2016
Q4
$727K Buy
6,300
+3,700
+142% +$412K 0.01% 605
2016
Q3
$272K Sell
2,600
-1,200
-32% -$125K 0.01% 808
2016
Q2
$370K Sell
3,800
-1,100
-22% -$104K 0.01% 687
2016
Q1
$471K Sell
4,900
-2,000
-29% -$182K 0.02% 537
2015
Q4
$625K Buy
+6,900
New +$649K 0.02% 599
2014
Q4
Sell
-26,300
Closed -$2.1M 1382
2014
Q3
$2.1M Buy
+26,300
New +$1.98M 0.04% 445
2014
Q2
Sell
-12,400
Closed -$918K 1360
2014
Q1
$918K Sell
12,400
-5,400
-30% -$407K 0.02% 686
2013
Q4
$1.4M Buy
+17,800
New +$1.39M 0.02% 653

Other funds holding CME

Integral Derivatives's CME Position: Q4 2017 in Review

Integral Derivatives sold out of CME Group (CME) in Q4 2017, closing a stake of 2,648 shares — an estimated $377K sold.

Integral Derivatives first reported a position in CME in Q4 2014 and held it in 2 quarters. The position peaked at $359K in Q3 2017. 855 funds tracked by Wall St. Rank hold CME as of Q4 2017.

  • Integral Derivatives reported no remaining CME Group position as of Q4 2017 after selling out during the quarter.
  • Integral Derivatives sold 2,648 CME Group shares in Q4 2017, an estimated $377K.
  • Integral Derivatives first reported a position in CME Group in Q4 2014 and held it in 2 quarters.
  • Integral Derivatives's CME Group position peaked at $359K in Q3 2017.
  • 855 funds tracked by Wall St. Rank held CME Group as of Q4 2017.

Based on Integral Derivatives's 13F filing for Q4 2017, filed 14 Feb 2018.